Prevantics® Device Swab & Strip

SKU # C71200, B19600 & B123ST
Description

Prevantics Device Swab is conveniently designed to help disinfect needleless access sites and helps improve ‘scrub the hub’ compliance to better protect against CLABSIs.

Our 3.15% Chlorhexidine Gluconate and 70% Isopropyl Alcohol Device Swab’s disinfecting formula, mechanical friction scrub, and fast 5 second scrub and 5 second dry times work together to help lower CLABSI rates. Prevantics Device Swab is available in two convenient formats, including a strip format for IV poles to ensure point-of-care accessibility.

Accessories & Compliance Tools
C71200_Prevantics-Device-Large-Swab_Box_800x800_02212024

Large Swab

SKU # C71200

Packaging: 10/150s

Dimensions: 1.59" x 2"

Front Label

  • 52% larger than the Prevantics Device Swab
  • Contains the first and only 3.15% Chlorhexidine Gluconate and 70% Isopropyl Alcohol formulation.
  • Quick 5 second scrub time and 5 second dry time helps with staff compliance.
    Intuitive prep-pad design.
  • 1.2 mL.
  • Each box contains 150 swabs.
Prevantics-Device-with-Swab

Swab

SKU # B19600

Packaging: 10/100's

Dimensions: 1.59" x 1.31"

Front Label Back Label

  • Conveniently designed to help disinfect needleless access sites.
  • Contains the first and only 3.15% Chlorhexidine Gluconate and 70% Isopropyl Alcohol formulation.
  • Quick 5 second scrub time and 5 second dry time helps with staff compliance.
  • Intuitive prep-pad design.
  • 1mL.
  • Each box contains 100 swabs.
Prevantics-Device-Swab-Strip-box

Strip

SKU # B123ST

Packaging: 10/160's

Dimensions: 1.59" x 1.31"

Front Label Back Label

  • Hangs conveniently on an IV pole for point-of-care accessibility.
  • 8 swabs per strip (each box contains 20 strips)
  • Each strip comes with hang tab attached.
  • Conveniently designed to help disinfect needleless access sites.
  • Contains the first and only 3.15% Chlorhexidine Gluconate and 70% Isopropyl Alcohol formulation.
  • Quick 5 second scrub time and 5 second dry time helps with staff compliance.
Scrub and Dry Time
  • 5 second scrub time followed by 5 second dry time
Formulation
  • 3.15% (w/v) chlorhexidine gluconate (CHG) and 70% (v/v) isopropyl alcohol (IPA)
Applicator
  • Intuitive, easy-to-use prep pad format provides friction to remove microorganisms from grooves and threads of connectors
Efficacy
  • Achieved a >4.0 log10 reduction versus a leading alcohol impregnated cap1 against 7 tested clinically relevant microorganisms known to cause CLABSIs2
Guideline Recommended
  • Effectively scrub the hub prior to and between each line access, as recommended in the Infusion Nurse Society (INS) Guidelines
FDA Cleared
  • First and only 3.15% CHG/70% IPA swab to receive 510(k) clearance from the US Food and Drug Administration (FDA) for disinfecting needleless access sites prior to use
Convenient Format
  • Strip format hangs conveniently on an IV pole for point-of-care accessibility
Use Sites
  • Disinfecting needleless access sites (needleless connectors, injection ports, and access ports) and tops of blood culture collection bottles.
Independent Data
  • Over 15 independent clinical studies demonstrating clinical efficacy of Prevantics products
Compliance
  • US Centers for Disease Control and Prevention
  • Infusion Nurses Society
  • Society for Healthcare Epidemiology of America
  • The Joint Commission National Patient Safety Goals
  • Infectious Diseases Society of America
  • Association for Professionals in Infection Control and Epidemiology
  • Association for Vascular Access
  • How is Prevantics® Device Swab used?

    Show Answer

    Prevantics Device Swab is designed to disinfect needleless access sites (or to scrub the hub) prior to use as well as in between each line access. Prevantics Device Swab is used to scrub the access site for 5 seconds with drying of the access site for at least 5 seconds.

  • If I use the Prevantics® Device Swab product, will I still need to use an alcohol impregnated cap?

    Show Answer

    Not necessarily. If clinicians follow all existing infection prevention and control measures, such as hand hygiene, use of personal protective equipment, use of chlorhexidine-based skin antisepsis, etc. then the use of an alcohol impregnated cap may not be clinically indicated. This would be evaluated by ongoing surveillance of HAI rates.

  • What evidence-based clinical guidelines support the use of the Prevantics® Device Swab for disinfection of needleless access sites prior to use?

    Show Answer

    The following evidence-based clinical guidelines support the use of Chlorhexidine Gluconate/Alcohol for disinfection of needleless access sites prior to use:
    1. Guidelines for the Prevention of Intravascular Catheter-Related Infections, US Centers for Disease Control and Prevention (CDC)
    2. Standards of Practice, Infusion Nurses Society (INS)
    3. Strategies to Prevent Central-Line Associated Bloodstream Infections in Acute Care Hospitals, Society for Healthcare Epidemiology of America (SHEA)
    4. National Patient Safety Goals, The Joint Commission
    5. Clinical Practice Guidelines for Diagnosis and Management of Intravascular Catheter-Related Infection, Infectious Disease Society of America (IDSA)
    6. Elimination Guide to Infections in Hemodialysis Settings, Association for Professionals in Infection Control and Epidemiology (APIC) 

  • Where is Prevantics® Device Swab used?

    Show Answer

    Prevantics Device Swab is used on needleless access sites which include ports, hubs, connectors, dialysis connectors and blood collection applications. These needleless access sites are most commonly found on patients who require an IV (central line, mid-line, or peripheral line).

  • Why is the Prevantics® Device Swab solution beneficial?

    Show Answer

    By using an antiseptic to disinfect the needleless access site, you are decreasing the risk of the patient acquiring a bloodstream infection (BSI) which can be fatal to the patient. According to the CDC, “Disinfection of the devices with Chlorhexidine /alcohol solution appears to be most effective in reducing colonization”.

  • Some PDI products state "store at room temperature." What is the definition of room temperature?

    Show Answer

    For our EPA-regulated products, such as Sani-Cloth® and Sani-Prime™ brand products, room temperature is defined as an average temperature of 25◦ C (77◦ F) and within a temperature range of 15◦ C to 30◦ C (59◦ F to 86◦ F). For our FDA-regulated products, such as Prevantics® brand products, “controlled room temperature” indicates a temperature maintained thermostatically that encompasses the usual customary working environment of 20◦ C to 25◦ C (68◦ F to 77◦ F). SOURCE: USP 41-NF 36 General Notices and Requirements (August 1, 2013 First Supplements) Section 10.30.50. “Room Temperature” indicates the temperature prevailing in a working area. Section 10.30.60. Controlled Room Temperature

  • What important information can be found on the Master Label?

    Show Answer
    • Company name and address
    • EPA Registration number – indicates which company holds the registration for the pesticide product, and in what sequence the product was submitted to EPA by the company.
    • EPA Establishment number – The final physical location where the pesticide product was produced or labeled.
    • Efficacy Claims
    • Product Toxicity category
    • Directions for use
    • Storage and Disposal Directions
    • Product contact time
    • First Aid and Precautionary statements
    • Marketing claims
  • What is a Master Label?

    Show Answer

    The Master Label contains all of the approved uses for a given pesticide product and all associated labeling. Master Labels must be submitted for EPA approval. EPA-approved Master Labels are stamped “ACCEPTED” and placed in the official record. Labeling for a given product must not contain any text beyond that which is approved in the Master Label, except for supplemental labeling. The Master Label provides critical information about how to handle and use the pesticide product.

1Data on file, study report 140304-250.
2CDC HAI Prevalence Survey. Magill SS, Edwards JR, Bamberg W, et al. Multistate Point-Prevalence Survey of Health Care–Associated Infections. N Engl J Med. 2014;370:1198-208.

Point of care accessories and compliance tools